1. Biopharma execs address the challenges of a post-pandemic workplace — Bristol Myers pays $200M upfront plus $1.36B in biobucks for Agenus' preclinical TIGIT asset — Novo Nordisk nets Ph2 win for former Corvidia kidney programSee more on our front page news
    Dismiss Notice

Philips Pathology

Anonymous Board for Philips Pathology

Sort By:
Title
Replies Views
Last Message
  1. Anonymous
    Replies:
    0
    Views:
    16,994

Thread Display Options

Loading...